Molecular Diagnostic for Infectious Diseases Market Forecast (2023-2030)
The molecular diagnostic for infectious diseases market size is projected to reach US$ 17,614.44 million by 2030 from US$ 6,883.03 million in 2022. The market is expected to register a CAGR of 12.5% during 2022–2030. Molecular diagnostics for infectious diseases in personalized medicine is likely to remain a key trend in the market.
Molecular Diagnostic for Infectious Diseases Market Analysis
The factors driving the market include the surging prevalence of infectious diseases globally and the rising application of molecular diagnostics in veterinary infectious diseases. Furthermore, rising awareness of simulation education has created growth opportunities for the molecular diagnostic for infectious diseases market over the upcoming forecast period. Demand for gynecological devices is being driven by a rise in gynecological illnesses, including ovarian cancer, cervical cancer, uterine cancer, vaginal cancer, and vulvar cancer. According to the American Cancer Society's 2022 update, women are often diagnosed with endometrial cancer at the age of 60. However, diagnoses before the age of 45 are uncommon.
Molecular Diagnostic for Infectious Diseases Market Overview
Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Infectious diseases are on the rise, necessitating accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases—including HIV, tuberculosis, hepatitis C, human papillomavirus screening for cervical cancer, and sexually transmitted infections, as well as outbreaks of infections—can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a significant problem in most African countries due to limited healthcare resources and the high disease burden. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. These pathogens include malaria parasites, Salmonella enterica and hemorrhagic viruses. It is impossible to detect life-threatening pathogens reliably with only culture results. Therefore, efficient molecular diagnostics are essential in areas with high infectious disease burdens.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Molecular Diagnostic for Infectious Diseases Market: Strategic Insights
Market Size Value in US$ 6,883.03 million in 2022 Market Size Value by US$ 17,614.44 million by 2030 Growth rate CAGR of 12.5% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Molecular Diagnostic for Infectious Diseases Market: Strategic Insights
| Market Size Value in | US$ 6,883.03 million in 2022 |
| Market Size Value by | US$ 17,614.44 million by 2030 |
| Growth rate | CAGR of 12.5% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Molecular Diagnostic for Infectious Diseases Market Drivers and Opportunities
Rising Application of Molecular Diagnostics in Veterinary Infectious Diseases
Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential for reducing economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally for detecting animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, susceptible, and specific, with the ability to detect at a high volume.
Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10–35 kg that is carried at the field level and used for validating African swine fever virus, avian influenza virus, classical swine fever virus, and foot-and-mouth disease virus for research purposes. Thus, molecular diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals can replace the conventional methods such as serological, microscopic, and culture-based techniques.
Advancements in Molecular Diagnostics Technologies
Genetic and genomic research has led to the development of molecular diagnostic techniques that focus on nucleic acid detection, which provide new methods for detecting infectious diseases with a fast turnaround time. A molecular diagnostic technique detects multiple pathogens and analyzes drug-resistant genes of pathogens and pathogen homology analysis, making it an increasingly important tool for the early diagnosis of infectious diseases. Molecular diagnostic techniques and platforms are used in all areas of anatomic and clinical pathologies. DNA or RNA sequences associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected via molecular diagnostic tests. Conventionally, CT scans, hematological tests, and reverse transcription-PCR (RT-PCR) were used for testing. Due to growing infectious diseases, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Collaborative efforts by scientific communities in different countries to manage infectious diseases and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which will likely create significant opportunities for the molecular diagnostics for infectious diseases market in the future.
Molecular Diagnostic for Infectious Diseases Market Report Segmentation Analysis
Key segments that contributed to the derivation of the molecular diagnostic for infectious diseases market analysis are product and end user.
- Based on type, the molecular diagnostic for infectious diseases market is segmented into point-of-care testing, laboratory testing. The laboratory testing segment held a larger market share in 2022.
- Based on application, the molecular diagnostic for infectious diseases market is segmented into point-of-care testing, laboratory testing. The laboratory testing segment held a larger market share in 2022.
- Based on disease type, the molecular diagnostic for infectious diseases market is segmented into point-of-care testing, laboratory testing. The laboratory testing segment held a larger market share in 2022.
- Based on infection type, the molecular diagnostic for infectious diseases market is segmented into point-of-care testing, laboratory testing. The laboratory testing segment held a larger market share in 2022.
- Based on end user, the molecular diagnostic for infectious diseases market is segmented by point of care testing, laboratory testing. The laboratory testing segment held a larger market share in 2022.
Molecular Diagnostic for Infectious Diseases Market Share Analysis by Geography
The geographic scope of the molecular diagnostic for infectious diseases market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The North America molecular diagnostics for infectious diseases market has been segmented into the US, Canada, and Mexico. The increasing acceptance of technologically advanced products, a rise in research and development activities, the presence of large healthcare businesses, and the growing use of molecular diagnostics kits for infectious disease diagnosis are among the key factors propelling the growth of the molecular diagnostics for infectious diseases market in North America. The molecular diagnostics for infectious diseases market growth in the US is primarily driven by the increasing prevalence of infectious disease, rising geriatric population, and multiple product launches by key players. Aging is a prominent risk factor for renal diseases. According to a study published by the Population Reference Bureau in 2020, the population of individuals aged 65 and above was 55 million in the US in 2020, and the number is expected to hike up to 95 million by 2060. Regulatory agencies in the US are devising favorable policies for the development of point-of-care (POC) products for the diagnosis and treatment of various indications.
Molecular Diagnostic for Infectious Diseases Market Report Scope
Molecular Diagnostic for Infectious Diseases Market News and Recent Developments
The Molecular Diagnostic for Infectious Diseases Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the molecular diagnostic for infectious diseases market are listed below:
- Thermo Fisher Scientific launched PCR kits for infectious disease detection in India. Thermo Fisher Scientific announced that its Applied Biosystems TaqPath PCR kits for infectious diseases such as multi-drug-resistant tuberculosis (MTB MDR), M. tuberculosis complex (MTB), hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and for genetic analysis (HLA B27) have received licensing rights by the Central Drugs Standard Control Organisation (CDSCO) and will be manufactured in India in association with Mylab Discovery Solutions. (Source: Thermo Fisher Scientific Inc, Company Website, February 2023)
- Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel. With the introduction of new IVD workflows, kits, software and reference libraries for mycobacteria and fungi, the company further expand the applications of established MALDI Biotyper platform. This creates additional value for all current and future customers. The new LiquidArray Gastrointestinal is a next-generation syndromic panel with amazing pathogen coverage. It is ideal for laboratories which are interested in a broad screening approach to detect most pathogens in one run. (Source: Bruker Corp, Company Website, April 2023)
Molecular Diagnostic for Infectious Diseases Market Report Coverage and Deliverables
The “Molecular Diagnostic for Infectious Diseases Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- Molecular diagnostic for infectious diseases market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Molecular diagnostic for infectious diseases market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Molecular diagnostic for infectious diseases market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the molecular diagnostic for infectious diseases market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, End User, Application, Disease Type, Infection Type, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the market include surging prevalence of infectious disease globally and rising application of molecular diagnostics in veterinary infectious diseases. However, limitations associated with molecular testing hinders the market growth.
F.Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, bioMerieux SA, Danaher Corp, Hologic Inc, Siemens Healthineers AG, Bruker Corp, Molzym GmbH & Co KG, and DiaSorin SpA.
North America dominated the molecular diagnostic for infectious diseases market in 2022
The market is expected to register a CAGR of 12.5% during 2022–2030.
Molecular diagnostics for infectious diseases in personalized medicine is likely to remain a key trend in the market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Molecular Diagnostic for Infectious Diseases Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Molecular Diagnostic for Infectious Diseases Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Surging Prevalence of Infectious Disease Globally
5.1.2 Rising Application of Molecular Diagnostics in Veterinary Infectious Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics for Infectious Diseases in Personalized Medicine
5.5 Impact Analysis:
6. Molecular Diagnostic for Infectious Diseases Market - Global Market Analysis
6.1 Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 – 2030
7. Global Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)
7.3 Point-of-Care Testing
7.3.1 Overview
7.3.2 Point-of-Care Testing: Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Laboratory Testing
7.4.1 Overview
7.4.2 Laboratory Testing: Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by End User, 2022 & 2030 (%)
8.2.1 Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
8.2.2 Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
9. Global Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)
9.3 Point-of-Care Testing
9.3.1 Overview
9.3.2 Global: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
9.4 Laboratory Testing
9.4.1 Overview
9.4.2 Global: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
10. Global Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 – by Disease Type
10.1 Overview
10.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)
10.3 Point-of-Care Testing
10.3.1 Overview
10.3.2 Global: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
10.3.2.1 Global: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
10.4 Laboratory Testing
10.4.1 Overview
10.4.2 Global: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
10.4.2.1 Global: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
11. Global Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 – by Infection Type
11.1 Overview
11.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)
11.3 Point-of-Care Testing
11.3.1 Overview
11.3.2 Global: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
11.4 Laboratory Testing
11.4.1 Overview
11.4.2 Global: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12. Molecular Diagnostic for Infectious Diseases Market - Geographical Analysis
12.1 North America Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast To 2030
12.1.1 Overview
12.1.2 North America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.1.3 North America: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.1.4 North America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.1.5 North America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.1.6 North America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.1.7 North America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.1.8 North America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.1.8.1 North America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.1.9 North America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.1.9.1 North America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.1.10 North America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.1.11 North America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.1.12 North America Molecular Diagnostic for Infectious Diseases Market, by Country
12.1.12.1 US
12.1.12.1.1 US Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.1.12.1.2 US: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.1.12.1.3 US: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.1.12.1.4 US: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.1.12.1.5 US: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.1.12.1.6 US: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.1.12.1.7 US: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.1.12.1.7.1 US: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.1.12.1.8 US: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.1.12.1.8.1 US: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.1.12.1.9 US: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.1.12.1.10 US: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.1.12.2 Canada
12.1.12.2.1 Canada Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.1.12.2.2 Canada: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.1.12.2.3 Canada: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.1.12.2.4 Canada: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.1.12.2.5 Canada: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.1.12.2.6 Canada: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.1.12.2.7 Canada: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.1.12.2.7.1 Canada: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.1.12.2.8 Canada: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.1.12.2.8.1 Canada: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.1.12.2.9 Canada: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.1.12.2.10 Canada: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.1.12.3 Mexico
12.1.12.3.1 Mexico Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.1.12.3.2 Mexico: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.1.12.3.3 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.1.12.3.4 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.1.12.3.5 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.1.12.3.6 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.1.12.3.7 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.1.12.3.7.1 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.1.12.3.8 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.1.12.3.8.1 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.1.12.3.9 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.1.12.3.10 Mexico: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2 Europe Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030
12.2.1 Overview
12.2.2 Europe Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.3 Europe: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.4 Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.5 Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.6 Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.7 Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.8 Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.8.1 Europe: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.9 Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.9.1 Europe: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.10 Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.11 Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12 Europe Molecular Diagnostic for Infectious Diseases Market, by Country
12.2.12.1 UK
12.2.12.1.1 UK Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.1.2 UK: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.1.3 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.1.4 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.1.5 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.1.6 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.1.7 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.1.7.1 UK: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.1.8 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.1.8.1 UK: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.1.9 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.1.10 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.2 Germany
12.2.12.2.1 Germany Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.2.2 Germany: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.2.3 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.2.4 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.2.5 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.2.6 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.2.7 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.2.7.1 Germany: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.2.8 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.2.8.1 Germany: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.2.9 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.2.10 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.3 France
12.2.12.3.1 France Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.3.2 France: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.3.3 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.3.4 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.3.5 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.3.6 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.3.7 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.3.7.1 France: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.3.8 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.3.8.1 France: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.3.9 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.3.10 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.4 Italy
12.2.12.4.1 Italy Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.4.2 Italy: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.4.3 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.4.4 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.4.5 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.4.6 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.4.7 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.4.7.1 Italy: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.4.8 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.4.8.1 Italy: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.4.9 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.4.10 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.5 Spain
12.2.12.5.1 Spain Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.5.2 Spain: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.5.3 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.5.4 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.5.5 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.5.6 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.5.7 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.5.7.1 Spain: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.5.8 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.5.8.1 Spain: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.5.9 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.5.10 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.6 Austria
12.2.12.6.1 Austria Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.6.2 Austria: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.6.3 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.6.4 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.6.5 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.6.6 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.6.7 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.6.7.1 Austria: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.6.8 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.6.8.1 Austria: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.6.9 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.6.10 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.7 Belgium
12.2.12.7.1 Belgium Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.7.2 Belgium: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.7.3 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.7.4 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.7.5 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.7.6 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.7.7 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.7.7.1 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.7.8 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.7.8.1 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.7.9 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.7.10 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.8 Luxembourg
12.2.12.8.1 Luxembourg Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.8.2 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.8.3 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.8.4 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.8.5 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.8.6 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.8.7 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.8.7.1 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.8.8 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.8.8.1 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.8.9 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.8.10 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.9 The Netherlands
12.2.12.9.1 The Netherlands Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.9.2 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.9.3 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.9.4 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.9.5 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.9.6 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.9.7 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.9.7.1 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.9.8 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.9.8.1 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.9.9 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.9.10 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.10 Rest of Europe
12.2.12.10.1 Rest of Europe Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.2.12.10.2 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.2.12.10.3 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.2.12.10.4 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.2.12.10.5 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.2.12.10.6 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.2.12.10.7 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.10.7.1 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.2.12.10.8 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.2.12.10.8.1 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.2.12.10.9 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.2.12.10.10 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3 Asia Pacific Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030
12.3.1 Overview
12.3.2 Asia Pacific Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.3 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.4 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.5 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.6 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.7 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.8 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.8.1 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.9 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.9.1 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.10 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.11 Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12 Asia Pacific Molecular Diagnostic for Infectious Diseases Market, by Country
12.3.12.1 China
12.3.12.1.1 China Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.1.2 China: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.1.3 China: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.1.4 China: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.1.5 China: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.1.6 China: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.1.7 China: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.1.7.1 China: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.1.8 China: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.1.8.1 China: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.1.9 China: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.1.10 China: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.2 Japan
12.3.12.2.1 Japan Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.2.2 Japan: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.2.3 Japan: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.2.4 Japan: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.2.5 Japan: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.2.6 Japan: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.2.7 Japan: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.2.7.1 Japan: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.2.8 Japan: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.2.8.1 Japan: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.2.9 Japan: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.2.10 Japan: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.3 India
12.3.12.3.1 India Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.3.2 India: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.3.3 India: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.3.4 India: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.3.5 India: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.3.6 India: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.3.7 India: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.3.7.1 India: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.3.8 India: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.3.8.1 India: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.3.9 India: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.3.10 India: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.4 South Korea
12.3.12.4.1 South Korea Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.4.2 South Korea: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.4.3 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.4.4 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.4.5 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.4.6 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.4.7 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.4.7.1 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.4.8 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.4.8.1 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.4.9 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.4.10 South Korea: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.5 Malaysia
12.3.12.5.1 Malaysia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.5.2 Malaysia: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.5.3 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.5.4 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.5.5 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.5.6 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.5.7 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.5.7.1 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.5.8 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.5.8.1 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.5.9 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.5.10 Malaysia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.6 Indonesia
12.3.12.6.1 Indonesia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.6.2 Indonesia: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.6.3 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.6.4 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.6.5 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.6.6 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.6.7 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.6.7.1 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.6.8 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.6.8.1 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.6.9 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.6.10 Indonesia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.7 Rest of Asia Pacific
12.3.12.7.1 Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.3.12.7.2 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.3.12.7.3 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.3.12.7.4 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.3.12.7.5 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.3.12.7.6 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.3.12.7.7 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.7.7.1 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.3.12.7.8 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.3.12.7.8.1 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.3.12.7.9 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.3.12.7.10 Rest of Asia Pacific: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.4 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030
12.4.1 Overview
12.4.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.4.3 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.4.4 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.4.5 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.4.6 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.4.7 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.4.8 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.4.8.1 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.4.9 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.4.9.1 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.4.10 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Country
12.4.11.2 Saudi Arabia
12.4.11.2.1 Saudi Arabia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.4.11.2.2 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.4.11.2.3 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.4.11.2.4 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.4.11.2.5 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.4.11.2.6 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.4.11.2.7 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.2.7.1 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.4.11.2.8 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.2.8.1 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.4.11.2.9 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.2.10 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.3 South Africa
12.4.11.3.1 South Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.4.11.3.2 South Africa: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.4.11.3.3 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.4.11.3.4 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.4.11.3.5 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.4.11.3.6 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.4.11.3.7 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.3.7.1 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.4.11.3.8 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.3.8.1 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.4.11.3.9 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.3.10 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.4 UAE
12.4.11.4.1 UAE Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.4.11.4.2 UAE: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.4.11.4.3 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.4.11.4.4 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.4.11.4.5 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.4.11.4.6 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.4.11.4.7 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.4.7.1 UAE: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.4.11.4.8 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.4.8.1 UAE: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.4.11.4.9 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.4.10 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.5 Rest of Middle East & Africa
12.4.11.5.1 Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.4.11.5.2 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.4.11.5.3 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.4.11.5.4 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.4.11.5.5 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.4.11.5.6 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.4.11.5.7 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.5.7.1 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.4.11.5.8 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.4.11.5.8.1 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.4.11.5.9 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.4.11.5.10 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.5 South & Central America Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030
12.5.1 Overview
12.5.2 South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.5.3 South & Central America: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.5.4 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.5.5 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.5.6 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.5.7 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.5.8 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.5.8.1 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.5.9 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.5.9.1 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.5.10 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.5.11 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.5.12 South & Central America Molecular Diagnostic for Infectious Diseases Market, by Country
12.5.12.1 Brazil
12.5.12.1.1 Brazil Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.5.12.1.2 Brazil: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.5.12.1.3 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.5.12.1.4 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.5.12.1.5 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.5.12.1.6 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.5.12.1.7 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.5.12.1.7.1 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.5.12.1.8 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.5.12.1.8.1 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.5.12.1.9 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.5.12.1.10 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
12.5.12.2 Rest of South & Central America
12.5.12.2.1 Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
12.5.12.2.2 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020–2030 (US$ Million)
12.5.12.2.3 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020–2030 (US$ Million)
12.5.12.2.4 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020–2030 (US$ Million)
12.5.12.2.5 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020–2030 (US$ Million)
12.5.12.2.6 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020–2030 (US$ Million)
12.5.12.2.7 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020–2030 (US$ Million)
12.5.12.2.7.1 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020–2030 (US$ Million)
12.5.12.2.8 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020–2030 (US$ Million)
12.5.12.2.8.1 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020–2030 (US$ Million)
12.5.12.2.9 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020–2030 (US$ Million)
12.5.12.2.10 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020–2030 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Abbott Laboratories
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 bioMerieux SA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Danaher Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Hologic Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Siemens Healthineers AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Bruker Corp
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Molzym GmbH & Co KG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 DiaSorin SpA
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms
List of Tables
Table 1. Molecular Diagnostic for Infectious Diseases Market Segmentation
Table 2. Global Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 3. Global Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 4. Global Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. Global Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. Global Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. Global Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 8. Global Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Global Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 10. Global Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. Global Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. North America Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. North America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. North America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 15. North America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. North America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. North America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. North America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 19. North America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 20. North America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 21. North America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 22. North America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. US Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. US Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 25. US Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. US Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 27. US Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 28. US Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 29. US Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 30. US Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 31. US Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 32. US Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. US Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 34. Canada Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. Canada Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 36. Canada Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 37. Canada Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 38. Canada Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 39. Canada Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 40. Canada Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 41. Canada Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Canada Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 43. Canada Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 44. Canada Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 45. Mexico Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 46. Mexico Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 47. Mexico Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 48. Mexico Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 49. Mexico Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 50. Mexico Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. Mexico Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 52. Mexico Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 53. Mexico Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 54. Mexico Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 55. Mexico Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 56. Europe Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 57. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 59. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 60. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 62. Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 63. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 64. Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 65. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 66. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 67. UK Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 68. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 69. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 70. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 71. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 72. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 73. UK Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 74. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 75. UK Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 76. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 77. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. Germany Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 79. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 80. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 81. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 82. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 83. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 84. Germany Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 85. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 86. Germany Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 87. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 88. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 89. France Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 90. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 91. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 92. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 93. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 94. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 95. France Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 96. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 97. France Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 98. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 99. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 100. Italy Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 101. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 102. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 103. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 104. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 105. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 106. Italy Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 107. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 108. Italy Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 109. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 110. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 111. Spain Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 112. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 113. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 114. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 115. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 116. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 117. Spain Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 118. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 119. Spain Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 120. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 121. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 122. Austria Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 123. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 124. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 125. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 126. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 127. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 128. Austria Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 129. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 130. Austria Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 131. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 132. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 133. Belgium Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 134. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 135. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 136. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 137. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 138. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 139. Belgium Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 140. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 141. Belgium Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 142. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 143. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 144. Luxembourg Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 145. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 146. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 147. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 148. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 149. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 150. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 151. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 152. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 153. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 154. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 155. The Netherlands Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 156. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 157. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 158. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 159. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 160. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 161. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 162. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 163. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 164. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 165. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 166. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 167. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 168. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 169. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 170. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 171. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 172. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 173. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 174. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 175. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 176. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 177. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 178. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 179. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 180. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 181. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 182. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 183. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 184. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 185. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 186. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 187. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 188. China Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 189. China Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 190. China Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 191. China Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 192. China Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 193. China Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 194. China Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 195. China Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 196. China Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 197. China Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 198. China Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 199. Japan Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 200. Japan Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 201. Japan Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 202. Japan Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 203. Japan Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 204. Japan Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 205. Japan Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 206. Japan Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 207. Japan Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 208. Japan Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 209. Japan Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 210. India Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 211. India Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 212. India Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 213. India Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 214. India Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 215. India Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 216. India Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 217. India Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 218. India Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 219. India Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 220. India Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 221. South Korea Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 222. South Korea Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 223. South Korea Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 224. South Korea Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 225. South Korea Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 226. South Korea Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 227. South Korea Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 228. South Korea Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 229. South Korea Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 230. South Korea Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 231. South Korea Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 232. Malaysia Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 233. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 234. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 235. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 236. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 237. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 238. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 239. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 240. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 241. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 242. Malaysia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 243. Indonesia Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 244. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 245. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 246. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 247. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 248. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 249. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 250. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 251. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 252. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 253. Indonesia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 254. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 255. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 256. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 257. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 258. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 259. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 260. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 261. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 262. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 263. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 264. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 265. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 266. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 267. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 268. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 269. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 270. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 271. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 272. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 273. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 274. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 275. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 276. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 277. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 278. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 279. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 280. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 281. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 282. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 283. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 284. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 285. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 286. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 287. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 288. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 289. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 290. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 291. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 292. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 293. South Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 294. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 295. South Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 296. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 297. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 298. UAE Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 299. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 300. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 301. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 302. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 303. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 304. UAE Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 305. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 306. UAE Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 307. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 308. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 309. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 310. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 311. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 312. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 313. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 314. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 315. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 316. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 317. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 318. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 319. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 320. South & Central America Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 321. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 322. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 323. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 324. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 325. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 326. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 327. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 328. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 329. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 330. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 331. Brazil Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 332. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 333. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 334. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 335. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 336. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 337. Brazil Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 338. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 339. Brazil Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 340. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 341. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 342. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 343. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 344. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User – Revenue and Forecast to 2030 (US$ Million)
Table 345. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 346. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application – Revenue and Forecast to 2030 (US$ Million)
Table 347. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 348. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing – Revenue and Forecast to 2030 (US$ Million)
Table 349. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type – Revenue and Forecast to 2030 (US$ Million)
Table 350. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing – Revenue and Forecast to 2030 (US$ Million)
Table 351. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 352. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type – Revenue and Forecast to 2030 (US$ Million)
Table 353. Organic Developments Done By Companies
Table 354. Inorganic Developments Done By Companies
Table 355. Glossary of Terms, Molecular Diagnostic for Infectious Diseases Market
List of Figures
Figure 1. Molecular Diagnostic for Infectious Diseases Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Molecular Diagnostic for Infectious Diseases Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)
Figure 8. Point-of-Testing: Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Laboratory Testing: Molecular Diagnostic for Infectious Diseases Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by End User, 2022 & 2030 (%)
Figure 11. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)
Figure 12. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)
Figure 13. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)
Figure 14. North America: Molecular Diagnostic for Infectious Diseases Market, by Key Country – Revenue (2022) (US$ Million)
Figure 15. North America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 16. North America Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)
Figure 17. US Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 18. Canada Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Mexico Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 20. Europe Molecular Diagnostic for Infectious Diseases Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 21. Europe Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Europe Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)
Figure 23. UK Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Germany Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. France Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Italy Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Spain Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Austria Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Belgium Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Luxembourg Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. The Netherlands Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Rest of Europe Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 34. Asia Pacific Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Asia Pacific Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)
Figure 36. China Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Japan Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. India Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. South Korea Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Malaysia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Indonesia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Rest of Asia Pacific Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 44. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)
Figure 46. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. South Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. UAE Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. South & Central America Molecular Diagnostic for Infectious Diseases Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 51. South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. South & Central America Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)
Figure 53. Brazil Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Molecular Diagnostics for Infectious Diseases Market
- F. Hoffmann-La Roche Ltd
- Abbott
- Thermo Fisher Scientific Inc
- bioMérieux SA
- Danaher
- Digene and International Murex Technologies
- Hologic
- Siemens Healthcare Private Limited
- Bruker Corporation
- Molzym
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For